Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
26 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/26/2953819/0/en/Enlivex-Receives-Authorization-from-the-Danish-Medicines-Agency-to-Initiate-the-Phase-II-Stage-of-its-Phase-I-II-Trial-of-Allocetra-in-Patients-with-Moderate-to-Severe-Knee-Osteoar.html
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/24/2952170/0/en/Enlivex-Announces-Positive-DSMB-Recommendation-to-Initiate-the-Phase-II-Stage-of-its-Phase-I-II-Trial-of-Allocetra-in-Patients-with-Moderate-to-Severe-Knee-Osteoarthritis.html
23 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/23/2917164/0/en/Enlivex-Receives-Regulatory-Authorization-For-The-Initiation-Of-A-Phase-I-Clinical-Trial-To-Evaluate-Allocetra-In-Patients-With-Psoriatic-Arthritis.html
24 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/24/2902937/0/en/Enlivex-Announces-the-Dosing-of-the-First-Patient-in-a-Randomized-Placebo-Controlled-Phase-I-II-Trial-Evaluating-AllocetraTM-in-up-to-46-Patients-with-Thumb-Osteoarthritis.html
20 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/20/2901651/0/en/Join-Enlivex-Therapeutics-Chief-Executive-Officer-for-a-Live-Investor-Webinar-and-Q-A-Session-on-June-25.html
17 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/17/2899579/0/en/Enlivex-Announces-Positive-Interim-Data-Readout-from-a-Phase-I-II-Trial-Evaluating-Allocetra-in-End-Stage-Knee-Osteoarthritis.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?